Cargando…

Editorial: Novel Therapeutic Potential for Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP), Vasoactive Intestinal Peptide (VIP) and Related Peptides in Cognition Deficits

Detalles Bibliográficos
Autores principales:	Ciranna, Lucia, Reglodi, Dora, Chow, Billy K., Vaudry, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cellular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473805/ https://www.ncbi.nlm.nih.gov/pubmed/34588958 http://dx.doi.org/10.3389/fncel.2021.748970

Ejemplares similares

Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Against Cognitive Decline in Neurodegenerative Diseases
por: Solés-Tarrés, Irene, et al.
Publicado: (2020)

Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide
por: Atlasz, Tamas, et al.
Publicado: (2018)

Lack of Pituitary Adenylate Cyclase–Activating Polypeptide (PACAP) Disturbs Callus Formation
por: Józsa, Gergő, et al.
Publicado: (2019)

The Role of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Signaling in the Hippocampal Dentate Gyrus
por: Johnson, Gregory C., et al.
Publicado: (2020)

The Neuropeptide Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Is Protective in Inflammation and Oxidative Stress-Induced Damage in the Kidney
por: Horvath, Gabriella, et al.
Publicado: (2019)

Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and Sudden Infant Death Syndrome: A Potential Model for Investigation
por: Tóth, Dénes, et al.
Publicado: (2023)

Signalling Alterations in Bones of Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Gene Deficient Mice
por: Józsa, Gergő, et al.
Publicado: (2018)

Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Oxidative Stress in Zebrafish Hair Cells
por: Kasica, Natalia, et al.
Publicado: (2016)

Tracing the Origins of the Pituitary Adenylate-Cyclase Activating Polypeptide (PACAP)
por: Cardoso, João C. R., et al.
Publicado: (2020)

Hearing impairment and associated morphological changes in pituitary adenylate cyclase activating polypeptide (PACAP)-deficient mice
por: Fulop, Daniel Balazs, et al.
Publicado: (2019)

Immunomodulatory Effects of the Neuropeptide Pituitary Adenylate Cyclase-Activating Polypeptide in Acute Toxoplasmosis
por: Figueiredo, Caio Andreeta, et al.
Publicado: (2019)

Intestinal Microbiota Changes in Mice Lacking Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) – Bifidobacteria Make the Difference
por: Heimesaat, Markus M., et al.
Publicado: (2017)

Calcitonin Gene-Related Peptide (CGRP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Migraine Pathogenesis
por: Christensen, Casper Emil, et al.
Publicado: (2022)

Effects of Pituitary Adenylate Cyclase Activating Polypeptide on Cell Death
por: Horvath, Gabriella, et al.
Publicado: (2022)

Corrigendum: Tracing the Origins of the Pituitary Adenylate-Cyclase Activating Polypeptide (PACAP)
por: Cardoso, João C. R., et al.
Publicado: (2020)

Targeting enkephalins and pituitary adenylate cyclase-activating polypeptide (PACAP) in migraine
por: Ashina, Messoud
Publicado: (2022)

Age-related alterations of articular cartilage in pituitary adenylate cyclase–activating polypeptide (PACAP) gene–deficient mice
por: Szegeczki, Vince, et al.
Publicado: (2019)

Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Reduces Oxidative and Mechanical Stress-Evoked Matrix Degradation in Chondrifying Cell Cultures
por: Szentléleky, Eszter, et al.
Publicado: (2019)

Pituitary adenylate cyclase-activating polypeptide (PACAP) has a neuroprotective function in dopamine-based neurodegeneration in rat and snail parkinsonian models
por: Maasz, Gabor, et al.
Publicado: (2017)

Pituitary adenylate cyclase-activating polypeptide (PACAP) in zebrafish models of nephrotic syndrome
por: Eneman, Benedicte, et al.
Publicado: (2017)

Endogenous Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Plays a Protective Effect Against Noise-Induced Hearing Loss
por: Ruel, Jérôme, et al.
Publicado: (2021)

Comprehensive behavioral analysis of pituitary adenylate cyclase-activating polypeptide (PACAP) knockout mice
por: Hattori, Satoko, et al.
Publicado: (2012)

Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Signalling Exerts Chondrogenesis Promoting and Protecting Effects: Implication of Calcineurin as a Downstream Target
por: Juhász, Tamás, et al.
Publicado: (2014)

Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Pathway Is Induced by Mechanical Load and Reduces the Activity of Hedgehog Signaling in Chondrogenic Micromass Cell Cultures
por: Juhász, Tamás, et al.
Publicado: (2015)

Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
por: Ashina, Messoud, et al.
Publicado: (2018)

Pituitary adenylate cyclase-activating polypeptide (PACAP) acts in the nucleus accumbens to reduce hedonic drive
por: Hurley, Matthew M., et al.
Publicado: (2018)

Pituitary Adenylate Cyclase Activating Peptide (PACAP) Participates in Adipogenesis by Activating ERK Signaling Pathway
por: Arsenijevic, Tatjana, et al.
Publicado: (2013)

Presence and Effects of Pituitary Adenylate Cyclase Activating Polypeptide Under Physiological and Pathological Conditions in the Stomach
por: Reglodi, Dora, et al.
Publicado: (2018)

Pituitary Adenylate Cyclase-Activating Polypeptide: A Promising Neuroprotective Peptide in Stroke
por: Fang, Yuanjian, et al.
Publicado: (2020)

SUN-484 Effect of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in the Regulation of Hypothalamic Kisspeptin Expression
por: Kanasaki, Haruhiko, et al.
Publicado: (2019)

Relationship between Plasma Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Level and Proteome Profile of Cows
por: Czegledi, Levente, et al.
Publicado: (2022)

Stress-related disorders, pituitary adenylate cyclase—activating peptide (PACAP)ergic system, and sex differences
por: Ramikie, Teniel S., et al.
Publicado: (2016)

Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Protects Striatal Cells and Improves Motor Function in Huntington’s Disease Models: Role of PAC1 Receptor
por: Solés-Tarrés, Irene, et al.
Publicado: (2022)

Correlation of Decreased Serum Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Levels With Non-motor Symptoms in Patients With Parkinson’s Disease
por: Hu, Shiyu, et al.
Publicado: (2021)

Pituitary adenylate cyclase activating polypeptide and migraine
por: Zagami, Alessandro S, et al.
Publicado: (2014)

PS16. Genetic variation and expression diversity of pituitary adenylate cyclase-activating polypeptide (PACAP) gene in mouse
por: Koide, Tsuyoshi, et al.
Publicado: (2016)

Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Physiological and Pathological Processes within the Gastrointestinal Tract: A Review
por: Karpiesiuk, Aleksandra, et al.
Publicado: (2021)

Pituitary adenylate cyclase-activating polypeptide (PACAP) contributes to the proliferation of hematopoietic progenitor cells in murine bone marrow via PACAP-specific receptor
por: Xu, Zhifang, et al.
Publicado: (2016)

Examination of pituitary adenylate cyclase-activating polypeptide in Parkinson’s disease focusing on correlations with motor symptoms
por: Pham, Daniel, et al.
Publicado: (2022)

Diabetes Affects the Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)-Like Immunoreactive Enteric Neurons in the Porcine Digestive Tract
por: Palus, Katarzyna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qmkhhnkorb4r9sotkchlgt678e